ArticleFrontiers in immunology2018

Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8

Sue D Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.